Advertisement



More in Pharmacy

As mpox cases rise globally, many Americans at high risk of contracting the virus are struggling to access the Jynneos vaccine due to its high cost and gaps in insurance coverage, The New York Times reported Nov. 4.  Here are…

As the U.S. healthcare industry mitigates a critical shortage of intravenous fluids, experts predict the supply strain will alleviate by early December, Bloomberg reported Nov. 5. 

The FDA issued a warning to patients and healthcare professionals to refrain from using compounded drugs distributed by Ontario, Calif.-based Fullerton Wellness, expressing concerns about the sterility of the drugs following reports of contamination. 

Wegovy may significantly reduce hospital admissions for any cause and overall length of stay, according to a new analysis of data from Novo Nordisk's phase 3 SELECT trial. 

A survey by the American Society of Health-System Pharmacists found that 50% of active drug shortages in the U.S. persist for two or more years, the Pharmacy Times reported Nov. 1. 

A Novo Nordisk Phase 3 trial found that 37% of adults with metabolic dysfunction-associated steatohepatitis who received once-weekly semaglutide 2.4 milligrams showed improvement in liver fibrosis without worsening steatohepatitis, a disease that causes the body to store excess fat in…

Two drug companies will pay a combined $49.1 million for their alleged involvement in schemes to inflate drug prices and limit competition in the generic pharmaceuticals market nationwide, the Connecticut Law Tribune reported Oct. 31. 

Advertisement
Advertisement
Advertisement